SCHEMBL282830

SCHEMBL282830

Nc1ccc(-c2ccc(-c3ccccc3)cc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 1.00
TDP1 Q9NUW8 3/20 1.00
TAAR1 Q96RJ0 3/20 1.00
HSD17B10 Q99714 2/20 1.00
ALDH1A1 P00352 7/20 0.73
TP53 P04637 1/20 0.73
MAPT P10636 6/20 0.62
RAB9A P51151 3/20 0.62
NPC1 O15118 2/20 0.62
HPGD P15428 2/20 0.62
KDM4E B2RXH2 2/20 0.62
GLA P06280 1/20 0.62
ALOX15 P16050 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
TSHR P16473 1/20 0.62
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
MAOA P21397 4/20 0.57
CYP1A2 P05177 3/20 0.50
CYP2C9 P11712 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Biphenyl-4-Amine SCHEMBL62469 1.00 CYP3A4 (1.00) CYP3A4TDP1TAAR1HSD17B10ALDH1A1
Biphenyl-4-Amine SCHEMBL27682012 1.00 CYP3A4 (1.00) CYP3A4TDP1TAAR1HSD17B10ALDH1A1
Benzidine SCHEMBL28050418 1.00 CYP3A4 (1.00) CYP3A4TDP1TAAR1HSD17B10ALDH1A1
Benzidine SCHEMBL308333 1.00 CYP3A4 (1.00) CYP3A4TDP1TAAR1HSD17B10ALDH1A1
Biphenyl-4-Amine SCHEMBL20296849 1.00 CYP3A4 (1.00) CYP3A4TDP1TAAR1HSD17B10ALDH1A1
SCHEMBL24524183 1.00 CYP3A4 (1.00) CYP3A4TDP1TAAR1HSD17B10ALDH1A1
Benzidine SCHEMBL29002343 1.00 CYP3A4 (1.00) CYP3A4TDP1TAAR1HSD17B10ALDH1A1
Biphenyl-4-Amine SCHEMBL15921057 1.00 CYP3A4 (1.00) CYP3A4TDP1TAAR1HSD17B10ALDH1A1
SCHEMBL21392391 1.00 CYP3A4 (1.00) CYP3A4TDP1TAAR1HSD17B10ALDH1A1
Biphenyl-4-Amine SCHEMBL28973472 0.97 CYP3A4 (0.94) CYP3A4TDP1TAAR1HSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 409 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116960342-A Preparation method and application of nanoscale TPA/PEDOT composite film with uniform thickness 吉林大学 2023-10-27 CN claimed
CN-108011094-B Preparation method of composite positive electrode material of lithium-sulfur battery 上海交通大学 2020-08-04 CN claimed
CN-108011094-A A kind of preparation method of lithium-sulfur battery composite anode material 上海交通大学 2018-05-08 CN claimed
CN-106328391-A Preparation method and application of covalent organic framework composite material and combination electrode 上海交通大学 2017-01-11 CN claimed
CN-105949463-A Preparation method and application of macroporous covalent organic framework 上海交通大学 2016-09-21 CN claimed
CN-105295044-A Preparation method and application of macroporous covalent organic framework UNIV SHANGHAI JIAOTONG 2016-02-03 CN claimed
US-12622134-B2 Organic electroluminescent device, and electronic apparatus HODOGAYA CHEMICAL CO., LTD. (JP) 2026-05-05 US disclosed
EP-3620448-B1 AMINE-BASED COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEMICAL LTD (KR) 2026-04-08 EP disclosed
EP-4667474-A2 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE Samsung Display Co., Ltd. (KR) 2025-12-24 EP disclosed
US-12503459-B2 Light emitting device and amine compound for the same SAMSUNG DISPLAY CO., LTD. (KR) 2025-12-23 US disclosed
EP-3909946-B1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO LTD (KR) 2025-12-17 EP disclosed
US-12492168-B2 Organic material for an electronic optoelectronic device and electronic device comprising the organic material NOVALED GMBH (DE) 2025-12-09 US disclosed
US-20250374828-A1 ORGANIC COMPOUND SEMICONDUCTOR ENERGY LAB (JP) 2025-12-04 US disclosed
WO-1996040202-A1 SYNTHESIS OF N-SUBSTITUTED OLIGOMERS CHIRON CORPORATION (US) 1996-12-19 WO disclosed
EP-0721970-A1 Polyimide based resin composition MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-07-17 EP disclosed
US-5480871-A TREATMENT OF BENIGN PROSTATIC HYPERPLASIA CHIRON CORPORATION (US) 1996-01-02 US disclosed
EP-0671928-A1 SYNTHESIS OF N-SUBSTITUTED OLIGOMERS CHIRON CORPORATION (US) 1995-09-20 EP disclosed
US-5447916-A Hypotensive agents CHIRON CORPORATION (US) 1995-09-05 US disclosed
WO-1995004072-A1 PEPTOID ALPHA-1 ADRENERGIC RECEPTOR LIGANDS CHIRON CORPORATION (US) 1995-02-09 WO disclosed
WO-1994006451-A1 SYNTHESIS OF N-SUBSTITUTED OLIGOMERS CHIRON CORPORATION (US) 1994-03-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12492168-B2 Organic material for an electronic optoelectronic device and electronic device comprising the organic material OCIAD1, OCIAD2, OR10J3 CYP3A4 796/4885TDP1 4032/4885TAAR1 2750/4885
US-12622134-B2 Organic electroluminescent device, and electronic apparatus KCNN1, KCNN2, ITGA1 CYP3A4 3118/4885TDP1 3603/4885TAAR1 810/4885
US-12503459-B2 Light emitting device and amine compound for the same SLC1A2, SLC18A1, ALDH1A2 CYP3A4 1274/4885TDP1 1144/4885TAAR1 13/4885
US-20250374828-A1 ORGANIC COMPOUND SUN2, ORC3, EML4 CYP3A4 4/4885TDP1 3283/4885TAAR1 3779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.